Reduction of the washout time between natalizumab and fingolimod

Mult Scler. 2013 Aug;19(9):1248. doi: 10.1177/1352458513490551. Epub 2013 May 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Propylene Glycols / administration & dosage*
  • Sphingosine / administration & dosage
  • Sphingosine / analogs & derivatives*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Natalizumab
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine